T1	Age 2 13	46-year-old
T2	Personal_background 14 23	Caucasian
T3	Sex 24 29	woman
T4	History 35 59	type 2 diabetes mellitus
T5	History 64 80	bipolar disorder
T6	Clinical_event 81 90	presented
E1	Clinical_event:T6 
T7	Nonbiological_location 98 118	emergency department
R1	MODIFY Arg1:T7 Arg2:E1	
T8	Sign_symptom 130 148	abdominal symptoms
E2	Sign_symptom:T8 
T9	Detailed_description 124 129	vague
R2	MODIFY Arg1:T9 Arg2:E2	
T10	Sign_symptom 153 161	vomiting
E3	Sign_symptom:T10 
T11	History 194 220	left below knee amputation
T12	History 225 246	right toes amputation
T13	History 251 297	complications secondary to diabetic neuropathy
T14	Sign_symptom 374 379	ulcer
E4	Sign_symptom:T14 
T15	Detailed_description 365 373	diabetic
T16	Detailed_description 356 364	infected
R3	MODIFY Arg1:T15 Arg2:E4	
R4	MODIFY Arg1:T16 Arg2:E4	
T17	Biological_structure 387 397	right foot
R5	MODIFY Arg1:T17 Arg2:E4	
T18	Disease_disorder 438 442	CAPD
E5	Disease_disorder:T18 
T19	Disease_disorder 459 472	renal disease
E6	Disease_disorder:T19 
A1	POLARITY E5 NEG
A2	POLARITY E6 NEG
T20	Diagnostic_procedure 474 484	creatinine
E7	Diagnostic_procedure:T20 
T21	Diagnostic_procedure 497 516	blood urea nitrogen
E8	Diagnostic_procedure:T21 
T22	Diagnostic_procedure 517 522	(BUN)
E9	Diagnostic_procedure:T22 
R6	IDENTICAL Arg1:E9 Arg2:E8	
T23	Lab_value 523 531	16 mg/dL
T24	Lab_value 485 495	1.23 mg/dL
R7	MODIFY Arg1:T24 Arg2:E7	
R8	MODIFY Arg1:T23 Arg2:E8	
T25	Diagnostic_procedure 537 557	blood glucose levels
E10	Diagnostic_procedure:T25 
T26	Lab_value 563 580	poorly controlled
R9	MODIFY Arg1:T26 Arg2:E10	
T27	Medication 598 605	insulin
E11	Medication:T27 
T28	Administration 585 597	subcutaneous
T29	Administration 606 615	injection
R10	MODIFY Arg1:T29 Arg2:E11	
R11	MODIFY Arg1:T28 Arg2:E11	
T30	Lab_value 632 665	range of 400 to 500 mg/dL at home
R12	MODIFY Arg1:T30 Arg2:E10	
T32	Diagnostic_procedure 701 721	blood glucose levels
E12	Diagnostic_procedure:T32 
T33	Lab_value 751 767	175 to 378 mg/dL
R14	MODIFY Arg1:T33 Arg2:E12	
T34	Medication 803 810	insulin
E13	Medication:T34 
T35	Detailed_description 794 802	stricter
T36	Detailed_description 811 818	regimen
R15	MODIFY Arg1:T36 Arg2:E13	
R16	MODIFY Arg1:T35 Arg2:E13	
T37	Diagnostic_procedure 850 857	CT scan
E14	Diagnostic_procedure:T37 
T38	Detailed_description 837 849	non-contrast
R17	MODIFY Arg1:T38 Arg2:E14	
T39	Sign_symptom 906 921	hypoattenuation
E15	Sign_symptom:T39 
T40	Detailed_description 865 874	confluent
T41	Biological_structure 876 883	bilobar
R18	MODIFY Arg1:T41 Arg2:E15	
R19	MODIFY Arg1:T40 Arg2:E15	
T42	Detailed_description 927 951	subcapsular distribution
R20	MODIFY Arg1:T42 Arg2:E15	
T43	Biological_structure 967 972	liver
R21	MODIFY Arg1:T43 Arg2:E15	
T44	Diagnostic_procedure 984 987	MRI
E16	Diagnostic_procedure:T44 
T45	Biological_structure 988 993	liver
R22	MODIFY Arg1:T45 Arg2:E16	
T46	Diagnostic_procedure 1185 1198	gradient echo
E17	Diagnostic_procedure:T46 
T47	Detailed_description 1176 1184	In-phase
R23	MODIFY Arg1:T47 Arg2:E17	
T48	Sign_symptom 1232 1236	foci
E18	Sign_symptom:T48 
T49	Detailed_description 1219 1231	hyperintense
R24	MODIFY Arg1:T49 Arg2:E18	
T50	Biological_structure 1244 1249	liver
R25	MODIFY Arg1:T50 Arg2:E18	
T51	Diagnostic_procedure 1673 1675	CT
E19	Diagnostic_procedure:T51 
T52	Biological_structure 1683 1690	abdomen
T53	Biological_structure 1695 1701	pelvis
T54	Disease_disorder 1643 1646	SHS
E20	Disease_disorder:T54 
#1	AnnotatorNotes E20	simple hepatic steatosis (or, non-alcoholic fatty liver disease)
T55	Date 1716 1730	3 months later
E21	Date:T55 
T56	Sign_symptom 1745 1769	near complete resolution
E22	Sign_symptom:T56 
T57	Diagnostic_procedure 1857 1876	blood glucose level
E23	Diagnostic_procedure:T57 
T58	Lab_value 1880 1895	below 200 mg/dL
R26	MODIFY Arg1:T58 Arg2:E23	
T59	Therapeutic_procedure 1815 1830	glucose control
E24	Therapeutic_procedure:T59 
T31	Clinical_event 674 694	poor drug compliance
E25	Clinical_event:T31 
R13	CAUSE Arg1:E25 Arg2:T30	
*	OVERLAP E1 E2 E3
R27	AFTER Arg1:E2 Arg2:E4	
*	OVERLAP E4 E5 E6
R28	BEFORE Arg1:E6 Arg2:E7	
*	OVERLAP E7 E8 E10 E11 E25
R29	BEFORE Arg1:E25 Arg2:E12	
*	OVERLAP E12 E13 E14 E15 E16 E18 E27 E29 E20
R30	SUB_PROCEDURE Arg1:E17 Arg2:E16	
T60	Diagnostic_procedure 1332 1354	opposed-phase sequence
E26	Diagnostic_procedure:T60 
R31	SUB_PROCEDURE Arg1:E26 Arg2:E16	
T61	Lab_value 1366 1380	loss in signal
T62	Sign_symptom 1415 1454	presence of intracellular fat and water
E27	Sign_symptom:T62 
R32	MODIFY Arg1:T61 Arg2:E26	
T63	Coreference 1565 1577	MR sequences
E28	Coreference:T63 
R33	IDENTICAL Arg1:E28 Arg2:E16	
T64	Sign_symptom 1590 1605	presence of fat
E29	Sign_symptom:T64 
T65	Biological_structure 1523 1541	hepatic parenchyma
R34	MODIFY Arg1:T65 Arg2:E29	
R35	BEFORE Arg1:E20 Arg2:E19	
R36	MODIFY Arg1:T52 Arg2:E19	
R37	MODIFY Arg1:T53 Arg2:E19	
*	OVERLAP E19 E21 E22 E24 E23
R38	CAUSE Arg1:E24 Arg2:T58	
